Response of WHO to KEI letter regarding McKinsey, vaccine policy and competing interests
On 20 February 2011, Dr. Keiji Fukuda, Assistant Director-General – Health Security and Environment, World Health Organization, responded to KEI’s letter (16 February 2011) regarding McKinsey, vaccine policy and competing interests. Here is the response in full (email contacts have been redacted).
From: “Fukuda, Keiji”
Date: February 20, 2011 4:14:05 PM GMT+01:00
To: “Thiru Balasubramaniam”
Continue ReadingSeven being considered for new US Register of Copyrights
Apparently it is now down to seven final candidates to be the new US Register of Copyrights. These include two employees of the Copyright Office (Carson and Kasunic), a lawyer in private practice (Fries), a full time professor (Brauneis), a professor/USPTO negotiator (Hughes), a trade negotiator (McCoy), and a representative of a trade association (Perlmutter). By gender, the finalists are two women, and five men.
They are, in alphabetical order:
Robert Brauneis
Continue Reading4 WBU suspends participation in WIPO & EU Stakeholder discussions, pending agreement at WIPO on legal framework
On February 26, 2011, the World Blind Union issued a statement announcing it would “suspend participation in the WIPO Stakeholder Platform and EU Stakeholder Dialogue projects, pending agreement at WIPO on a proper binding legal framework.” [See full statement below]. The WBU statement is expected to dramatically change the environment for considering a new WIPO treaty for persons who are blind or have other disabilities.
38 groups (including KEI) ask Congress to make CRS reports public
Congressional Research Service reports are prepared in response to requests from members of congress. For decades, right to know groups have been asking that they be available online. The CRS describes itself as follows:
KEI letter to WHO regarding McKinsey, vaccine policy and competing interests
On 15 February 2011, the Co-Chairs of the WHO Open-Ended Working Group of Member States on Pandemic Influenza Preparedness: sharing of influenza viruses and access to vaccines and other benefits (OEWG) held a consultation with civil society. The Co-chairs of the OEWG are Ambassador J. Gomez-Camacho, Mexico and Ambassador B. Angell-Hansen, Norway. Continue Reading
De Gucht responds to MEP Françoise Castex. Says ACTA is binding agreement, consistent with EU ‘acquis’
Noncommunicable diseases in the 2011 global public health agenda
Noncommunicable diseases (NCDs) enjoy a place of prominence on the global public health agenda in 2011. At the 128th WHO EB, the assembly was abuzz with news of a joint Russian and WHO initiative, the “First global ministerial conference on healthy lifestyles and noncommunicable disease control” to be held in Moscow on 28-29 April 2011 and the UN High-level Meeting of the General Assembly on Non-Communicable Diseases in September 2011.
KEI comments on Tibotec voluntary licenses of a new HIV-AIDS product
Today, Tibotec, a subsidiary of Johnson & Johnson, announced it has signed voluntary licensing agreements with several Indian and South African generic companies to allow generic competition on a new HIV-AIDS treatment, the investigational non-nucleoside reverse transcriptase inhibitor rilpivirine hydrochloride (TMC278) (rilpivirine hydrochloride), to certain developing countries. Continue Reading
Le Monde: L’OMS face à un nouveau conflit d’intérêts
The following is an article by Agathe Duparc which appeared on page four of the Sunday/Monday edition (23 January-24 January 2011) of Le Monde with a reference on the cover page. Below the article are two paragraphs providing readers with more background information on the World Health Assembly and the Executive Board. The third paragraph is the main quote highlighted in the print version. What is missing in this copy below is a cartoon accompanying the piece which shows a bespectacled man with a body of an octopus holding two syringes in a field of dollar signs. Continue Reading
WHO Conflict of Interest Guidelines
WHO has kindly made available its conflict of interest guidelines. Apparently they are not available from the public web page. Attached are two documents:
A few of the many interesting provisions follow:
I. MEANING OF “CONFLICT OF INTEREST”